HLA-DO

Content sourced from Wikipedia, licensed under CC BY-SA 3.0.

HLA-DO is a non-classical major histocompatibility complex (MHC) class II protein that forms a dimer from its alpha and beta chains. It works with HLA-DM to help fine-tune which peptide fragments are ultimately presented by MHC II to T cells. Unlike classical MHC II molecules, which are highly variable and present peptides to the immune system, HLA-DO is non-polymorphic and acts as a regulator rather than a presenter.

DO is mainly found in B cells, thymic medullary epithelial cells, and dendritic cells, suggesting it has an important role in shaping immune responses. HLA-DM can function without DO, but DO must be in complex with DM to stay stable. Interestingly, DO does not bind peptides itself; instead, it binds to DM at the peptide-exchange site and modulates how DM selects and loads peptides onto MHC II.

During antigen processing, DM helps replace a placeholder protein (CLIP) with a real peptide in the MHC II groove. DO accompanies DM during this exchange and influences which peptides are favored. This regulatory interaction may affect how the thymus selects immunodominant epitopes and how B cells present peptides.

Genetic and structural studies suggest DO is evolutionarily conserved and structurally similar to classical MHC II, though it has differences at the N-terminus. The exact shape of free DO is not fully known. Key discoveries came from mouse models (the H-2O system) and human cells in the 1980s and 1990s, with IFN-γ not inducing DO expression. Overall, HLA-DO appears to help tune the immune system by modulating DM’s peptide selection.